ArticleBriefings in bioinformatics2025
A transcriptional plasticity-aware framework for RNA-seq differential expression analysis.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Differential expression (DE) analysis based on transcriptomic data provides a genome-wide assessment of gene responsiveness. We recently characterized transcriptional plasticity (TP)-the variability of gene expression in response to environmental changes-but its impact on DE analysis remained unexplored. In this work, we examined how TP affects DE analysis and introduced a TP-aware framework to improve the interpretation of DE results. We revealed correlations between fold change of gene expression and TP in 238 experiments with Mycobacterium tuberculosis (Mtb) and Escherichia coli (E. coli), which carried inherent biases, favoring genes with high TP while overlooking those with low TP. Therefore, we employed Locally Estimated Scatterplot Smoothing on TP to adjust the fold change of gene expression. Adjusted DE analyses identified new responsive pathways and yielded higher overall statistical significance and enrichment scores, especially for pathways with low-TP genes. Specifically, adjusted DE results revealed that bedaquiline treatment of Mtb induced cholesterol degradation, linezolid repressed acetate metabolism, and infection of macrophages upregulated fatty acid metabolism while downregulating cofactor biosynthesis. We also demonstrate that the adjustment strategy can be applied to other bacterial species and is compatible with various RNA-seq quantification approaches. In summary, we introduce a TP-aware approach that normalizes DE analysis by correcting for inherent transcriptional variability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.